David A Spellman - Net Worth and Insider Trading

David A Spellman Net Worth

The estimated net worth of David A Spellman is at least $2 Million dollars as of 2025-07-23. David A Spellman is the SVP, CFO and Treasurer of Akebia Therapeutics Inc and owns about 446,483 shares of Akebia Therapeutics Inc (AKBA) stock worth over $2 Million. Details can be seen in David A Spellman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Spellman has not made any transactions after 2023-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of David A Spellman

To

David A Spellman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David A Spellman owns 2 companies in total, including Akebia Therapeutics Inc (AKBA) , and Mersana Therapeutics Inc (MRSN) .

Click here to see the complete history of David A Spellman’s form 4 insider trades.

Insider Ownership Summary of David A Spellman

Ticker Company Transaction Date Type of Owner
AKBA Akebia Therapeutics Inc 2023-05-16 SVP & CFO and Treasurer
MRSN Mersana Therapeutics Inc 2018-03-12 Chief Financial Officer

David A Spellman Latest Holdings Summary

David A Spellman currently owns a total of 1 stock. David A Spellman owns 446,483 shares of Akebia Therapeutics Inc (AKBA) as of May 16, 2023, with a value of $2 Million.

Latest Holdings of David A Spellman

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKBA Akebia Therapeutics Inc 2023-05-16 446,483 3.85 1,718,960

Holding Weightings of David A Spellman


David A Spellman Form 4 Trading Tracker

According to the SEC Form 4 filings, David A Spellman has made a total of 4 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 63,567 shares on May 16, 2023, which brought David A Spellman around $68,017.

Insider Trading History of David A Spellman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David A Spellman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David A Spellman Ownership Network

Ownership Network List of David A Spellman

No Data

Ownership Network Relation of David A Spellman

Insider Network Chart


David A Spellman Owned Company Details

What does Akebia Therapeutics Inc do?

Who are the key executives at Akebia Therapeutics Inc?

David A Spellman is the SVP & CFO and Treasurer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Medical Officer Steven Keith Burke , director & CEO & President John P. Butler , and SVP & CFO & CBO & Treasurer Erik Ostrowski .

Akebia Therapeutics Inc (AKBA) Insider Trades Summary

Over the past 18 months, David A Spellman made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 73,186 shares made by Steven Keith Burke , a net sale of 228,553 shares made by John P. Butler , and a net sale of 58,536 shares made by Richard C Malabre .

In summary, during the past 3 months, insiders sold 69,648 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 69,648 shares. During the past 18 months, 536,856 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 536,856 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akebia Therapeutics Inc Insider Transactions

No Available Data

David A Spellman Mailing Address

Above is the net worth, insider trading, and ownership report for David A Spellman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David A Spellman's mailing address is: Cambridge Ma 02139.